Investors sentiment is 0.96 in Q1 2019. Its the same as in 2018Q4. It is without change, as 45 investors sold MCD shares while 566 reduced holdings. only 140 funds opened positions while 449 raised stakes. 496.73 million shares or 3.19% less from 513.11 million shares in 2018Q4 were reported. […]
Investors sentiment increased to 1.44 in 2019 Q1. Its up 0.45, from 0.99 in 2018Q4. It improved, as 37 investors sold Neurocrine Biosciences, Inc. shares while 71 reduced holdings. 45 funds opened positions while 110 raised stakes. 101.77 million shares or 17.27% more from 86.79 million shares in 2018Q4 were […]
Analysts expect Cleveland-Cliffs Inc. (NYSE:CLF) to report $0.51 EPS on July, 19.They anticipate $0.25 EPS change or 32.89 % from last quarter’s $0.76 EPS. CLF’s profit would be $144.23M giving it 4.93 P/E if the $0.51 EPS is correct. After having $-0.08 EPS previously, Cleveland-Cliffs Inc.’s analysts see -737.50 % […]
Investors sentiment increased to 1.58 in Q1 2019. Its up 0.10, from 1.48 in 2018Q4. It improved, as 5 investors sold Flexsteel Industries, Inc. shares while 14 reduced holdings. 11 funds opened positions while 19 raised stakes. 4.95 million shares or 1.69% more from 4.87 million shares in 2018Q4 were […]
Investors sentiment increased to 1.14 in Q1 2019. Its up 0.15, from 0.99 in 2018Q4. It is positive, as 46 investors sold WCG shares while 132 reduced holdings. 82 funds opened positions while 121 raised stakes. 48.09 million shares or 8.86% less from 52.77 million shares in 2018Q4 were reported. […]
Investors sentiment decreased to 1.01 in 2019 Q1. Its down 0.01, from 1.02 in 2018Q4. It turned negative, as 19 investors sold MTZ shares while 99 reduced holdings. 54 funds opened positions while 65 raised stakes. 70.24 million shares or 12.19% more from 62.61 million shares in 2018Q4 were reported. […]
Investors sentiment increased to 1.53 in Q1 2019. Its up 0.49, from 1.04 in 2018Q4. It improved, as 18 investors sold Western Alliance Bancorporation shares while 84 reduced holdings. 46 funds opened positions while 110 raised stakes. 84.00 million shares or 1.50% less from 85.28 million shares in 2018Q4 were […]
Trillium Therapeutics Inc. (NASDAQ:TRIL) Ratings Coverage Among 2 analysts covering Trillium Therapeutics (NASDAQ:TRIL), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Trillium Therapeutics had 4 analyst reports since March 12, 2019 according to SRatingsIntel. Leerink Swann maintained it with “Hold” rating and $1 target in […]
